Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Lucid Diagnostics Announces Data From ESOGUARD BE-1 Study; Demonstrates 87.5% Sensitivity And 98.6% NPV For EsoGuard Test; Strengthens Clinical Validity For Medicare LCD Pre-Submission And Commercial Payor Engagements; Cleveland VA Study Data Accepted For Peer-Reviewed Publication

Author: Benzinga Newsdesk | July 02, 2024 07:56am

Posted In: LUCD